Trending Topics

Loading trending topics...

See what’s trending right now
Heart healthin Health
4 hours ago

A new study highlights that just 7,000 daily steps can significantly reduce health risks, emphasizing "some is better than none," while another test offers deeper insights into heart attack risk.

William J. Rutter, Biotech Pioneer of Gene-Based Medicine, Dies at 97

The New York TimesSunday, July 27, 2025 at 2:38:43 PM
NeutralHealthBiotechnology
William J. Rutter, Biotech Pioneer of Gene-Based Medicine, Dies at 97
William J. Rutter, a trailblazer in biotechnology who helped lay the groundwork for gene-based medicine—including the development of the first recombinant DNA vaccine—has passed away at 97. His work revolutionized how we approach vaccines and treatments, paving the way for breakthroughs like the hepatitis B vaccine and modern mRNA technology.
Editor’s Note: Rutter’s legacy isn’t just about the past; it’s a reminder of how foundational science shapes the present. Without his contributions, we might not have the rapid vaccine development we saw during the pandemic. His death is a moment to appreciate the quiet architects of modern medicine—and how their work echoes for decades.
— Curated via WP Now’s

Was this article worth reading? Share it

Latest from Health
This Test Tells You More About Your Heart Attack Risk
PositiveHealth
A simple scan called coronary artery calcium testing can spot dangerous plaque buildup in your heart's arteries—giving doctors a clearer picture of your risk for a heart attack. But despite its potential to save lives, this test isn't being used as much as it should be.
William J. Rutter, Biotech Pioneer of Gene-Based Medicine, Dies at 97
NeutralHealth
William J. Rutter, a trailblazer in biotechnology who helped lay the groundwork for gene-based medicine—including the development of the first recombinant DNA vaccine—has passed away at 97. His work revolutionized how we approach vaccines and treatments, paving the way for breakthroughs like the hepatitis B vaccine and modern mRNA technology.
Tories would ban strikes by NHS doctors - Badenoch
NegativeHealth
The UK Conservative Party, led by Kemi Badenoch, is proposing to ban strikes by NHS doctors amid an ongoing pay dispute. Thousands of junior doctors are already on strike, escalating tensions between medical professionals and the government.
Thousands of Americans are being forced to switch from Zepbound to Wegovy as a result of new coverage restrictions by CVS Caremark. ‘I just wish they would trust my doctor.’
NegativeHealth
Thousands of Americans relying on the weight-loss drug Zepbound are being pushed to switch to Wegovy due to new insurance restrictions from CVS Caremark. While some are making the change to cut costs, others are fighting to stay on Zepbound, citing better results and fewer side effects. Many feel frustrated that insurers are overriding their doctors' recommendations.
An FDA panel spread misinformation about SSRI use in pregnancy. Doctors are concerned
NegativeHealth
A group of doctors is sounding the alarm after an FDA advisory panel downplayed the risks of antidepressants (SSRIs) during pregnancy and postpartum—despite evidence suggesting potential harms. Obstetricians and psychiatrists worry this could lead to poor medical decisions for vulnerable patients.

Why World Pulse Now?

Global Coverage

All major sources, one page

Emotional Lens

Feel the mood behind headlines

Trending Topics

Know what’s trending, globally

Read Less, Know More

Get summaries. Save time

Stay informed, save time
Learn more

Live Stats

Articles Processed

6,052

Trending Topics

150

Sources Monitored

191

Last Updated

4 hours ago

Live data processing
How it works

Mobile App

Available on iOS & Android

The mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.

Get it on Google PlayDownload on the App Store
Available now on iOS and Android

1-Minute Daily Briefing

Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more

By subscribing, you agree to our Privacy Policy